UK markets closed
  • NIKKEI 225

    29,538.73
    -229.33 (-0.77%)
     
  • HANG SENG

    28,453.28
    -245.52 (-0.86%)
     
  • CRUDE OIL

    59.74
    +0.42 (+0.71%)
     
  • GOLD FUTURES

    1,732.40
    -12.40 (-0.71%)
     
  • DOW

    33,668.22
    -132.38 (-0.39%)
     
  • BTC-GBP

    43,581.25
    -109.76 (-0.25%)
     
  • CMC Crypto 200

    1,279.98
    -14.60 (-1.13%)
     
  • ^IXIC

    13,836.11
    -64.08 (-0.46%)
     
  • ^FTAS

    3,933.89
    -15.62 (-0.40%)
     

CordenPharma enters into a technology alliance agreement with Nanos of South Korea

CordenPharma
·1-min read

SEOUL, South Korea, March 29, 2021 (GLOBE NEWSWIRE) -- CordenPharma of Germany entered into a technology alliance agreement with Nanos (151910 KOSDAQ) of South Korea relating to the production of Peptides.

Nanos is a top supplier of camera modules for Samsung Electronics’ mobile phone business.

Due to a relocation of Samsung Electronics’ mobile business to Vietnam, Nanos’ manufacturing factory in Hwasung, Korea, remains out of production.

Through in-licensing or a large-scale direct investment, Nanos plans to transform and utilize the existing production facility to launch high value products, such as Peptides, a potential agent for cancer immunotherapy drugs.

Nanos’ partnership with CordenPharma, one of the leading global development and manufacturing organizations (CDMO), represents Nanos’ strategic intention to establish long-term production and sale of therapeutic drugs involving Peptides, which are currently in Phase 2 clinical trials.

Press Contact: Kenny Bang
E-mail : supergto314151@gmail.com